Stockreport

We're Hopeful That Acrivon Therapeutics (NASDAQ:ACRV) Will Use Its Cash Wisely [Yahoo! Finance]

Acrivon Therapeutics, Inc.  (ACRV) 
PDF lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. But the harsh reality is that very many loss makin [Read more]